New letters urge the Centers for Medicare & Medicaid Services to expand Medicare and Medicaid to include FDA-approved ...
The Centers for Medicare and Medicaid Services (CMS) says about 8,247,000 people with Medicare Part D coverage use the ten drugs selected for price negotiation.
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
CMS issued the industry-wide ratings the next month. Among large insurers, UnitedHealthcare experienced one of the most ...
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...
Premier has called on CMS to enhance Medicare Advantage and Part D policies for 2026, emphasizing policies to protect access to care, particularly in rural areas.
An expanding prohibition on third-party financial guarantees could lead to more nursing home using lawsuits to collect unpaid ...
UnitedHealth (UNH) stock in focus as Medicare withdraws appeal over an unfavorable ruling related to the company's 2025-Star ...
Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...
The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...
“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...